Electrocortical therapy for motion sickness
Neurology
.
2015 Oct 6;85(14):1257-9.
doi: 10.1212/WNL.0000000000001989.
Epub 2015 Sep 4.
Authors
Qadeer Arshad
1
,
Niccolo Cerchiai
1
,
Usman Goga
1
,
Yuliya Nigmatullina
1
,
R Ed Roberts
1
,
Augusto P Casani
1
,
John F Golding
1
,
Michael A Gresty
1
,
Adolfo M Bronstein
2
Affiliations
1
From Imperial College (Q.A., N.C., U.G., Y.N., R.E.R., M.A.G., A.M.B.), Charing Cross Hospital, London, UK; Otorinolaringoiatria 1 Universitaria (N.C., A.P.C.), Pisa, Italy; and the University of Westminster (J.F.G.), London, UK.
2
From Imperial College (Q.A., N.C., U.G., Y.N., R.E.R., M.A.G., A.M.B.), Charing Cross Hospital, London, UK; Otorinolaringoiatria 1 Universitaria (N.C., A.P.C.), Pisa, Italy; and the University of Westminster (J.F.G.), London, UK.
[email protected]
.
PMID:
26341870
PMCID:
PMC4607597
DOI:
10.1212/WNL.0000000000001989
No abstract available
MeSH terms
Brain / physiopathology*
Electric Stimulation Therapy*
Humans
Motion Sickness / therapy*
Time Factors
Treatment Outcome
Grants and funding
MR/J004685/1/MRC_/Medical Research Council/United Kingdom